Research Topics
Species | W RzymanSummaryCountry: Poland Publications
| Collaborators
|
Detail Information
Publications
Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancerW Rzyman
Department of Thoracic Surgery, Medical University of Gdansk, ul Debinki 7, 80 211 Gdansk, Poland
Eur J Surg Oncol 32:462-5. 2006....
Lung function in patients operated for chronic pleural empyemaW Rzyman
Department of Thoracic Surgery, Medical University of Gdansk, Gdansk, Poland
Thorac Cardiovasc Surg 53:245-9. 2005..To evaluate lung function after lung decortication in patients operated for chronic pleural empyema...
[Thymectomy in myasthenia gravis]Witold Rzyman
Katedra i Klinika Chirurgii Klatki Piersiowej Akademii Medycznej w Gdańsku
Pol Merkur Lekarski 18:41-4. 2005..All patients underwent extended thymectomy by median sternotomy. Follow-up was assessed in 74 of 81(91.4%) patients, in the mean age of 39 +/- 15, discharged from the Department...
One step removal of dumb-bell tumors by postero-lateral thoracotomy and extended foraminectomyWitold Rzyman
Department of Thoracic Surgery, Medical University of Gdansk, Poland
Eur J Cardiothorac Surg 25:509-14. 2004..Surgical removal is the treatment of choice, performed by two teams - neurosurgeons and thoracic surgeons operating in a prescribed order...
Intraoperative, radio-guided sentinel lymph node mapping in 110 nonsmall cell lung cancer patientsWitold Rzyman
Department of Thoracic Surgery, Medical University of Gdansk, Gdansk, Poland
Ann Thorac Surg 82:237-42. 2006....
Fulminant thoracic sarcoma masked by hemothoraxWitold Rzyman
Department of Thoracic Surgery, Heart and Lung Center of Ullevaal University Hospital, Oslo, Norway
J Thorac Oncol 1:856. 2006
Primary malignant fibrous histiocytoma of the lungW Rzyman
Department of Thoracic Surgery, Medical University of Gdansk, Gdansk, Poland
Thorac Cardiovasc Surg 55:186-9. 2007..Its appearance as a primary lung tumor is extremely rare. The cell origin of MFH remains controversial. The treatment of choice for MFH is surgical resection, while the role of chemo- and radiotherapy remains unclear...
Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classificationJ Jassem
Departments of Oncology and Radiotherapy, Thoracic Surgery, Pneumonology, and Pathology, Medical University of Gdansk, Poland
J Thorac Cardiovasc Surg 119:1141-6. 2000..Prognostic relevance of the current TNM stage grouping for lung cancer is still a matter of debate...
P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinomaJacek Jassem
Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland
Cancer 100:1951-60. 2004....
Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lungMarcin Skrzypski
University of Gdansk, Gdansk, Poland
Clin Cancer Res 14:4794-9. 2008..Current staging methods are imprecise indications of prognosis, but high-risk patients can be identified by gene expression profiling and considered for adjuvant therapy...
Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancerDorota Dworakowska
Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Poland
Lung Cancer 66:127-33. 2009..04). This study demonstrates that joint analysis of several factors involved in apoptosis, proliferation and cell cycle regulation, but not AI alone, might provide additional prognostic information in NSCLC patients...
The influence of blood transfusion on survival in operated non-small cell lung cancer patientsWitold Rzyman
Department of Thoracic Surgery, Medical University of Gdansk, 7 Debinki Street, 80 211 Gdansk, Poland
J Thorac Cardiovasc Surg 126:755-60. 2003..The impact of autologous blood transfusion on survival has only occasionally been analyzed in cancer patients...
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphismAmelia Szymanowska
Department of Allergology, Medical University of Gdansk, Gdansk, Poland
Lung Cancer 52:9-14. 2006..Additionally, the correlation between Pro72 and somatic TP53 mutations suggests that Pro72 allele carriers may be predisposed to tumour development along a p53 associated form of NSCLC, a finding that warrants further investigations...
[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer]Amelia Szymanowska
Klinika Alergologii, AM w Gdańsku
Pneumonol Alergol Pol 73:264-9. 2005..The results of this study indicate that TP53 gene mutations in NSCLC patients are not correlated with clinical characteristics and have no impact on survival...
[Results of treatment for chronic pleural empyema]Witold Rzyman
Pneumonol Alergol Pol 71:43-50. 2003..It should be recommended that pleural drainage precede the surgical management of empyema. Delate of surgical intervention is the main cause of the high mortality rate in empyema following esophageal perforation...
BRCA1: a novel prognostic factor in resected non-small-cell lung cancerRafael Rosell
Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain
PLoS ONE 2:e1129. 2007....
Decortication in chronic pleural empyema - effect on lung functionWitold Rzyman
Department of Thoracic Surgery, Medical University of Gdansk, Gdansk, Poland
Eur J Cardiothorac Surg 21:502-7. 2002..The aim of the present study is to evaluate the lung function before and after the lung decortication in patients with chronic pleural empyema (CPE)...
[Chronic pleural empyema]Witold Rzyman
Pneumonol Alergol Pol 71:99-106. 2003
Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case reportRafal Dziadziuszko
Department of Medical Oncology, University of Colorado Cancer Center, Aurora, CO 80045, USA
J Thorac Oncol 2:91-2. 2007..Molecular characterization of the primary tumor before any treatment is provided, and mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors are briefly discussed...
